Article Versions Notes

Amaador K, Kersten MJ, Visser HPJ, Nieuwenhuizen L, Schop RFJ, Chamuleau MED, Velders GA, Minnema MC, Vos JMI. First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline. Hemato. 2022; 3(4):704-717. https://doi.org/10.3390/hemato3040047

Amaador, Karima, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, and Josephine Mathilde Iris Vos. 2022. "First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline" Hemato 3, no. 4: 704-717. https://doi.org/10.3390/hemato3040047

Amaador, K., Kersten, M. J., Visser, H. P. J., Nieuwenhuizen, L., Schop, R. F. J., Chamuleau, M. E. D., Velders, G. A., Minnema, M. C., & Vos, J. M. I. (2022). First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline. Hemato, 3(4), 704-717. https://doi.org/10.3390/hemato3040047